Repaglinide
Repaglinide is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.

Catalog Number | T1088 |
Alternative Name(s) | AG-EE 388 ZW , AG-EE 623ZW |
Research Area | DNA Damage/DNA Repair|||Membrane transporter/Ion channel|||Metabolism |
Molecular Formula | C27H36N2O4 |
CAS# | 135062-02-1 |
SMILES | [C@H](NC(CC1=CC(OCC)=C(C(O)=O)C=C1)=O)(CC(C)C)C2=C(C=CC=C2)N3CCCCC3 |
Size | 100 mg |
Supplier Page | https://www.targetmol.com/compound/Repaglinide |
Additional Information | https://www.targetmol.com/datasheet/T1088 |